Status:
UNKNOWN
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
Lead Sponsor:
Ramos Mejía Hospital
Conditions:
Acute Respiratory Distress Syndrome
COVID-19 Pneumonia
Eligibility:
All Genders
15+ years
Brief Summary
Respiratory failure associated with Covid-19 can be expressed as acute respiratory distress syndrome (ARDS), which is an acute inflammatory lung injury,which generally requires the use of invasive mec...
Detailed Description
During the first 7 days of the patient on mechanical ventilation (MV), measurements will be taken. For this, the patient will be in the supine position (DS) or the prone position (DP). The patient wil...
Eligibility Criteria
Inclusion
- \- Patients who have been receiving MV with diagnosis of ARDS (Berlin definition) and ARDS-Covid-19.
Exclusion
- Patients with chronic pulmonary disease
- Patients with a high risk of death within 3 months for reasons other than ARDS-Covid-19
- Patients having made the decision to withhold life-sustaining treatment.
Key Trial Info
Start Date :
March 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05248243
Start Date
March 7 2022
End Date
March 1 2025
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Agudos Ramos Mejía
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina, C1221ADC